Circulating tumor DNA (ctDNA) analysis of PIK3CA and AKT1 mutations in patients enrolled onto the Phase 1b study of the PI3K inhibitor taselisib (GDC-0032) in solid malignancies Meeting Abstract
| Authors: | Wilson, T. R.; Savage, H.; Aimi, J.; Jin, J.; Parmar, H.; Hsu, J.; Krop, I.; Saura, C.; Cervantes, A.; Sachdev, J.; Patel, M.; Cejalvo, J.; Oliveira, M.; Winer, E.; Von Hoff, D.; Baselga, J.; Juric, D. |
| Abstract Title: | Circulating tumor DNA (ctDNA) analysis of PIK3CA and AKT1 mutations in patients enrolled onto the Phase 1b study of the PI3K inhibitor taselisib (GDC-0032) in solid malignancies |
| Meeting Title: | 106th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 75 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 Apr 18-22 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-08-01 |
| Language: | English |
| ACCESSION: | WOS:000371578505001 |
| DOI: | 10.1158/1538-7445.am2015-2399 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2399 -- Proceedings of the 106th Annual Meeting of the American Association for Cancer Research -- Source: Wos |
